Dr. Christopher Joseph Lehmann, MD

Dr. Lehmann practices at The University of Chicago Medical Center in Chicago, Illinois.

Dr. Lehmann's NPI, 1154717809, was assigned on April 9, 2015. Dr. Lehmann holds Illinois license 036.149686.

Dr. Lehmann's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Lehmann's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Dr. Lehmann is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Lehmann to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lehmann practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Lehmann's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Lehmann's licenses on file in 2 states: Illinois and Indiana.

CMS data shows 108 Medicare services from Dr. Lehmann across 3 procedure codes in 2024, for 78 Medicare patients. Medicare paid $13,074 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Lehmann in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lehmann's median patient age at 68, with 50% women.

In 2024, Dr. Lehmann wrote 72 Medicare Part D claims for 17 patients. 74% of them were for generic drugs. CMS names the drug for 47 of them, across 4 drugs with 11 or more claims each, at $6,718 in total drug cost. In 2019, CMS named 78 claims across 5 drugs.

Dr. Lehmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lehmann as offering telehealth.

Dmand AI links 9 papers to Dr. Lehmann, published from 2012 to 2024. 2016 was the busiest year, with 2. The most frequent topics are COVID-19, Gastrointestinal Microbiome and SARS-CoV-2. Dr. Lehmann has published most often in MMWR Morb Mortal Wkly Rep. Dr. Lehmann's most frequent co-authors are Eric G. Pamer, MD, Andrew I. Aronsohn and Samina Bhumbra, MD.

CMS Open Payments shows 1 general payment to Dr. Lehmann from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $47.